IRS1 and neoplasm: Due to the increased expression levels of NE and its ability to generate an environment favorable to tumor cells by degrading the insulin receptor substrate-1 (IRS-1) and increasing the interaction of phosphatidylinositol 3-kinase (PI3K) and the potent platelet-derived growth factor mitogen receptor (PDGF) in CRC patients, Ho et al.